Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combination Chemotherapy
Clinical trial NCT02579616 · COMPLETED
Trial details
- NCT number
- NCT02579616
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-23
- Primary completion
- 2016-11-22
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.